Citations 247
IPSS-Molecular but Not Individual Mutations Predicts Outcomes of Patients with Myelodysplastic Syndrome (MDS) after Allogeneic Hematopoietic Cell Transplantation (Allo-HCT): A Mayo Clinic Cohort
Mohty, Razan , Vanegas, Yenny Moreno , Hochwald, Alexander , Kharfan‐Dabaja, Mohamed A. , Khera, Nandita , Litzow, Mark R. , Mangaonkar, Abhishek A. , Palmer, Jeanne , Sproat, Lisa Z., Viswanatha, David S., Foran, James M. , Heckman, Michael G. , Alkhateeb, Hassan B. , Hogan, William J. , Ketterling, Rhett P. , Murthy, Hemant S. , Shah, Meera
Blood | November 29, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 4863-4864
Molecular Predictors of Response and Survival in Patients with Relapsed/Refractory Acute Myeloid Leukemia Following Venetoclax Plus Hypomethylating Agent Therapy
Johnson, Isla McKerrow , Ilyas, Rimal, Al‐Kali, Aref , Begna, Kebede H. , Mangaonkar, Abhishek A. , Litzow, Mark R. , Patnaik, Mrinal M. , Pardanani, Animesh , Tefferi, Ayalew , Gangat, Naseema , McCullough, Kristen , Alkhateeb, Hassan B. , Hogan, William J. , Shah, Meera
Blood | November 29, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 3233-3234
Characteristics and Outcomes of Patients with BCOR Mutated Myeloid Neoplasms
Barua, Amit , Yıkılmaz, Aysun Şentürk , He, Rong , Viswanatha, David S., Katamesh, Bahga , Mangaonkar, Abhishek A. , Gangat, Naseema , Patnaik, Mrinal M. , Litzow, Mark R. , Begna, Kebede H. , Tefferi, Ayalew , Al‐Kali, Aref , Baranwal, Anmol , Shah, Meera , Badar, Talha , Hogan, William J. , Alkhateeb, Hassan B.
Blood | November 29, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 3235-3236
Predictors of Response to Venetoclax Plus Hypomethylating Agent Therapy and Survival in Blast-Phase Myeloproliferative Neoplasm
Gangat, Naseema , Ilyas, Rimal, Begna, Kebede H. , Al‐Kali, Aref , Patnaik, Mrinal M. , Litzow, Mark R. , Mangaonkar, Abhishek A. , Elliott, Michelle A. , Foran, James M. , Palmer, Jeanne , Hanson, Curtis A. , Pardanani, Animesh , Tefferi, Ayalew , McCullough, Kristen , Hogan, William J. , Alkhateeb, Hassan B. , Shah, Meera , Badar, Talha
Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 9675-9676
Clinical and Genetic Characteristics of STAG2 Mutations in Myeloid Neoplasms
Katamesh, Bahga , Nanaa, Ahmad , He, Rong , Viswanatha, David S., Nguyen, Phuong L., Bessonen, Kurt, Gangat, Naseema , Begna, Kebede H. , Mangaonkar, Abhishek A. , Patnaik, Mrinal M. , Tefferi, Ayalew , Litzow, Mark R. , Foran, James M. , Al‐Kali, Aref , Greipp, Patricia T. , Hogan, William J. , Shah, Meera , Yi, Cecilia Arana , Badar, Talha , Alkhateeb, Hassan B.
Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 12353-12354
TP53 Mutation Status Defines a Distinct Clinicopathological Entity of Therapy-Related Myeloid Neoplasm, Characterized By Genomic Instability and Extremely Poor Outcome
Sharplin, Kirsty, Chhetri, Rakchha , Ladon, Dariusz, Al‐Kali, Aref , Litzow, Mark R. , Mangaonkar, Abhishek A. , Gangat, Naseema , Patnaik, Mrinal M. , Begna, Kebede, Tefferi, Ayalew , Shah, Meera , Hahn, Christopher N , Tran, Elizabeth Ngoc Hoa , Baranwal, Anmol , Kutyna, Monika , Wang, Paul Po-Shen , Alkhateeb, Hassan B. , Ross, David M , Yeung, David , Shanmuganathan, Naranie , Hogan, William J. , Kumar, Sharad , Singhal, Deepak , Brown, Anna , Scott, Hamish S. , THOMAS, DANIEL W. , Kok, Chung Hoow , Hiwase, Devendra
Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 9798-9799
Clonal Hematopoiesis in Vexas Syndrome
Gutierrez‐Rodrigues, Fernanda , Kusne, Yael , Fernandez, Jenna A., Ma, Xiaoyang , Alessi, Hugh, Finke, Christy M. , Mangaonkar, Abhishek A. , Begna, Kebede H. , Viswanatha, David S., Wilson, Lorena, Kourelis, Taxiarchis , Reichard, Kaaren K. , Olteanu, Horatiu , Darden, Ivana, Hironaka, Dalton, Rosenzweig, Sofia , Kastner, Daniel L. , Grayson, Peter C. , Beck, David B. , Patnaik, Mrinal M. , Young, Neal S. , Patel, Bhavisha A. , Lasho, Terra L. , Shalhoub, Ruba N. , Koster, Matthew J. , Warrington, Kenneth J. , Xie, Zhuoer , Ombrello, Amanda K. , Ferrada, Marcela A. , Go, Ronald S. , Groarke, Emma M , Calvo, Katherine R. , Wu, Colin O.
Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 5745-5746
Outcome of Patients with Acute Myeloid Leukemia Following Failure of Front-Line Venetoclax Plus Hypomethylating Agent Therapy
Ilyas, Rimal, Johnson, Isla McKerrow , Al‐Kali, Aref , Begna, Kebede, Mangaonkar, Abhishek A. , Litzow, Mark R. , Patnaik, Mrinal M. , Pardanani, Animesh , Tefferi, Ayalew, Gangat, Naseema , McCullough, Kristen , Alkhateeb, Hassan B. , Hogan, William J. , Shah, Meera , Tefferi, Ayalew
Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 1286-1287
Response Rates to Venetoclax Based Therapies in Chronic Phase and Blast Transformed Chronic Myelomonocytic Leukemia
Litzow, Mark R. , Gangat, Naseema , Al‐Kali, Aref , Foran, James M. , Palmer, Jeanne , Mangaonkar, Abhishek A. , McCullough, Kirsten, Tefferi, Ayalew , Patnaik, Mrinal M. , Csizmar, Clifford M. , Saliba, Antoine N. , Hogan, William J. , McCullough, Kirsten, Alkhateeb, Hassan B.
Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 12238-12240
Phase II Study Assessing Safety and Preliminary Efficacy of High Dose Intravenous Ascorbic Acid in Patients with TET2 Mutant Clonal Cytopenias of Undetermined Significance
Finke, Christy M. , Amundson, Michelle Renee, LaPlant, Betsy, Mangaonkar, Abhishek A. , Gangat, Naseema , Reichard, Kaaren K. , Elliott, Michelle A. , Patnaik, Mrinal M. , Xie, Zhuoer , McCullough, Kristen , Lasho, Terra L. , Fernandez, Jenna , Witzig, Thomas E.
Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 2893-2894